Nexium Buyers Win Class Cert In AstraZeneca Antitrust MDL

Nexium Buyers Win Class Cert In AstraZeneca Antitrust MDL

A Massachusetts federal judge certified a class of Nexium end-buyers on Thursday who accused AstraZeneca PLC and others of violating antitrust laws by delaying a generic version of AstraZeneca’s heartburn drug, ruling the class met adequacy and ...read more

  • Tags: